Glaxo paying $20M to resolve SEC charges of China bribery

WASHINGTON (AP) ” GlaxoSmithKline PLC has agreed to pay $20 million to resolve U.S. regulators’ allegations that the pharmaceutical giant’s China operations bribed officials to boost drug sales.The Securities and Exchange Commission…